Overview

Learn everything you need to know about prostate MRI for the diagnosis and management of patients with prostate cancer on this two-day online course for urologists and other healthcare professionals. 

The prostate cancer-management pathway is moving towards image-guided diagnosis and treatment. This course will provide interactive teaching from a world-renowned faculty in prostate MRI interpretation.

It will equip you to be able to use MRI in the management of patients with prostate cancer and run an image-guided service. 

This year the course will be run virtually to widen access to potential participants during the COVID-19 pandemic. You will require a good and stable internet connection and access to a computer to participate

Places are limited to 50 people and there will be a waiting list in operation once this threshold has been reached.

Course content

The course will cover the following:

• The importance of prostate MRI to the urologist
• Recognising prostate anatomy on MRI
• Identifying areas suspicious for prostate cancer on multi-parametric MRI
• How to use MRI to help guide management decisions in prostate cancer patients
• Contouring the prostate on MRI prior to MRI-targeted biopsy and treatments
• Using MRI imaging to guide prostate biopsy
• PSMA-PET in the diagnosis and staging of prostate cancer.

The course now also includes:

• a dedicated expert planning session for robotic prostatectomy
• illustration on the use of MRI to plan focal therapy (e.g. HIFU, cryotherapy)

Who this course is for

This course is for healthcare professionals, including:

• urological consultants and trainees
• nurses
• radiologists
• allied health professionals interested in prostate cancer diagnosis.
• commercial companies with an interest in prostate cancer diagnosis.

Course structure and teaching

The course runs over two days, with the following learning format:

• Hands-on MRI interpretation workshop with expert faculty using real prostate MRIs
• Significant time to interpret new scans with individual feedback on performance (you'll be given access to software for viewing MRI scans on your home computer)
• Virtual demonstration demonstration of image-fusion software in MRI-targeted prostate biopsy
• Lectures and case-based discussions to demonstrate the role of MRI in the diagnosis and treatment of men with prostate cancer
• An ‘mpMRI clinic’ for radiologists to get feedback on the quality of their local mpMRI sequences and receive advice from our expert radiologists

CPD accreditation and certificates

12 CPD points have been accredited by the British Association of Urological Surgeons (BAUS), and you'll receive a certificate of attendance.

Learning outcomes

By the end of the course you should be able to:

• understand the importance of multi-parametric MRI interpretation for the practicing urologist
• recognise prostate anatomy on multi-parametric MRI
• identify areas suspicious for prostate cancer on multi-parametric MRI
• understand the limitations of prostate multi-parametric MRI
• recognise good and bad multi-parametric MRI scan quality and understand how to optimise this
• use multi-parametric MRI to help guide management decisions in prostate cancer patients (specifically, for the planning of robotic prostatectomy and focal therapy)
• contour the prostate on MRI prior to MRI-targeted biopsy and treatments
• use multi-parametric MRI to guide prostate biopsy
• understand the role of PSMA-PET in the diagnosis and staging of prostate cancer.

Cost

The fees for this course are as follows:

• Clinicians: £300
• Industry: £1,000

How you and your employer will benefit

UCL and UCLH are at the international forefront of prostate MRI research and use in clinical practice. Over 1000 MRI scans are performed at UCLH every year. UCL researchers have played a key role in the development and evaluation of this technology in clinical practice. The faculty comprise some of these key researchers and clinicians.

You'll also:

• benefit from networking opportunities with faculty
• have the opportunity to get involved in research in MRI-targeted biopsy
• be able to launch your own image-guided diagnostic services at your own trusts

Course team

Dr Clare Allen

Clare qualified from Oxford University and is Consultant Radiologist at UCL with an academic interest in uro-oncology, in particular prostate MR-imaging. She has a well-developed clinical practice in dynamic contrast-enhanced MR in the prostate and is leading a team of medical physicists in further defining the role of multi-sequence MRI in diagnostic utility of prostate cancer.

Mr Veeru Kasivisvanathan

Veeru is an NIHR Academic Clinical Lecturer in Urology and Hunterian Professor 2020. He completed a PhD evaluating the role of MRI-targeted biopsies in the diagnosis of prostate cancer and ran the PRECISION study which was published in The New England Journal of Medicine. He's part of the team that runs the diagnostic MRI-targeted biopsy service at UCLH and is responsible for the multi-disciplinary team management of these patients.

Dr Alex Kirkham

Alex is Consultant Radiologist at UCLH, specialising in urological radiology. He has both a clinical and a research interest in prostate cancer imaging, in particular MRI for the detection of tumour and the assessment of ablative therapies.

Professor Caroline Moore

Caroline is a Consultant Urological Surgeon at University College Hospital, and Professor of Urology in the Department of Targeted Intervention, UCL. She leads a significant research programme at UCL, focusing on MRI-targeted prostate biopsy, active surveillance and focal therapy for prostate cancer (such as PICTURE & SmartTarget) for which she’s also involved in numerous international collaborations.

Dr Francesco Giganti

Francesco is Associate Professor of Radiology at UCL and Honorary Consultant Radiologist at UCLH. He is an expert in teaching prostate MRI for radiologists and urologists, and part of the team commissioned by EAU to deliver Europe-wide training courses. His main areas of interest in prostate MRI are image quality (PI-QUAL score), active surveillance (PRECISE score) and imaging after focal ablation (PI-FAB score).

Professor Mark Emberton

Mark is Professor of Intervention Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at UCL. He's clinically active and holds the position of Honorary Consultant Urologist at University College London Hospitals NHS Trust where he works as a specialist in prostate cancer.

Also teaching on this course are Dr Dan Ho, Mr Alistair Grey, Mr Zafer Tandogdu, Dr Anita Mitra and Dr Louise Dickinson. With small group supervision by a number of experienced international faculty. 

Course information last modified: 18 Aug 2023, 14:48